Stomach inserts to control weight gain; Onciomed, Inc.; U.S. Pat. No. 8,100,932
March 5, 2012 1 Comment
The ‘932 patent discloses three cylindrical cages that can be placed within the stomach using a minimally-invasive procedure “to occupy volume and to cause a reduced desire for eating for treating obesity and controlling weight gain.” The first and third cylindrical cages have closed ends, while the second cylindrical cage has open ends and a hollow channel which slows emptying of the stomach since “a limited amount of food can travel through the hollow channel.”
According to its website, Onciomed is “focused on the development of proprietary, less invasive medical device technology for the treatment of obesity and diabetes,” and its GVS system “enables doctors to perform a procedure that can restrict the intake of food and provide the feeling of fullness.” Studies are currently underway for the safety and effectiveness of the GVS system and “it is not available for commercial use in the United States.”
The ‘932 patent is the first U.S. patent for Onciomed, according to the USPTO database.